Any further development efforts for either of our product candidates is dependent on our ability to raise additional capital.

Androxal®

Androxal® Type 2 Diabetes and Secondary Hypogonadism (ZA-202) (Currently recruiting)

Purpose: To determine the effect the investigative drug has on glycemic control in men with type 2 diabetes mellitus (T2DM) and secondary hypogonadism

Androxal® Normalization of Morning Testosterone Levels and Fertility (ZA-203) (Currently recruiting)

Purpose: To determine the effects of Androxal on morning testosterone and reproductive status in men with secondary hypogonadism (confirmed morning testosterone less than 250 ng/dL), compared to changes with placebo, or topical testosterone. The effects of topical testosterone versus placebo on reproductive status will also be examined. Study subjects must not be currently using a topical testosterone.

Proellex®

Proellex® Safety and Efficacy (ZP-204) (Currently recruiting)

Purpose: To determine the effects of five different doses of Proellex on menses, ovulation, liver function, and steady state exposure in women of reproductive age.